MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shackelford, R. E.
Right arrow Articles by Pizzo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shackelford, R. E.
Right arrow Articles by Pizzo, S.

0026-895X/97/030421-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:421-429 (1997).

Aspirin Inhibits Tumor Necrosis Factor-alpha Gene Expression in Murine Tissue Macrophages

Rodney E. Shackelford, Paul B. Alford, Yan Xue, Sheau-Fung Thai, Dolph O. Adams, and Salvatore Pizzo

Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710

Aspirin has been reported to inhibit the activation of nuclear factor-kappa B (NF-kappa B) through stabilization of inhibitor kappa B (Ikappa B). This observation led us to investigate the role of aspirin in suppressing the activation of the NF-kappa B-regulated tumor necrosis factor-alpha (TNF-alpha ) gene expression in primary macrophages. We now report that therapeutic doses of aspirin suppress lipopolysaccharide-inducible NF-kappa B binding to an NF-kappa B binding site in the TNF-alpha promoter, lipopolysaccharide-induced TNF-alpha mRNA accumulation, and protein secretion. Ikappa B is also stabilized under these conditions. The aspirin-initiated stabilization of Ikappa B, suppression of induced TNF-alpha mRNA, and NF-kappa B binding to the TNF-alpha promoter are blocked by pretreatment with pertussis toxin. These studies suggest that aspirin may exert significant anti-inflammatory effects by suppressing the production of macrophage-derived inflammatory mediators.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss
Inflammation and Endometrial Cancer: A Hypothesis
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Staniforth, S.-Y. Wang, L.-F. Shyur, and N.-S. Yang
Shikonins, Phytocompounds from Lithospermum erythrorhizon, Inhibit the Transcriptional Activation of Human Tumor Necrosis Factor {alpha} Promoter in Vivo
J. Biol. Chem., February 13, 2004; 279(7): 5877 - 5885.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. H. Zhu and E. L. Schwartz
Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-{alpha} and Inhibition by Aspirin
Mol. Pharmacol., November 1, 2003; 64(5): 1251 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
FASEB J, October 1, 2001; 15(12): 2057 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. S. Chapple, E. J. Cartwright, G. Hawcroft, A. Tisbury, C. Bonifer, N. Scott, A. C. J. Windsor, P. J. Guillou, A. F. Markham, P. L. Coletta, et al.
Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas
Am. J. Pathol., February 1, 2000; 156(2): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Oberle, T. Polte, A. Abate, H.-P. Podhaisky, and H. Schroder
Aspirin Increases Ferritin Synthesis in Endothelial Cells : A Novel Antioxidant Pathway
Circ. Res., May 19, 1998; 82(9): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics